There are various ways to target the EMT process in cancer which include (i) blocking the activation signal of EMT markers such as E-cadherin, N-cadherin vimentin, fibronectin, matrix metalloproteinases (MMPs), and TGF-β [48], (ii) reversed the EMT process, and (iii) suppressing the growth EMT-like cells. The gene discussed is TGFB1; the disease is cancer.